Introduction Depression is accounted as one of the major contributors towards the neuropsychiatric complication among person living with HIV. Depression leads to the non-compliance and accounted for the worst outcomes. So, this study was aimed to assess the prevalence and correlates of depression. Methods This was a cross-sectional study conducted at the Anti-retroviral therapy (ART) centre, RMRIMS, Patna, India. The study protocol was approved by the institutional ethics committee of Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna (04/RMRI/EC/2016). Patients were interviewed with the Patient Health Questionnaire (PHQ-9) to assess the prevalence of depression. Association of depression with respect to demographic and disease-related factors were also assessed. Data were coded and analysed using SPSS v22. Results A total of 144 patients suffering from HIV were participated in this study. Among this selected participants, 47% were female. The mean age of participants was 38.8 years (SD=11.4). Depression was prevalent in 57% (95% CI: 48.91 to 65.09) of patient participated in the study and was highly prevalent in female (66%). Prevalence of depression was higher in patient belongs to upper lower and lower socioeconomic class. More than a quarter 28% (95% CI: 21.56 to 36.44) of respondents had mild depression, while 29% (95% CI: 21.99 to 36.41) of participants were suffering from moderate to severe depression. Prevalence of depression was found to be significantly associated with lower socioeconomic class (OR 2.458, 95% CI 1.081-5.592; p<0.05). Conclusion Depression is highly prevalent among HIV-positive patients in Bihar region. Higher odds of prevalent depression were observed in lower socioeconomic class. Nearly 30% HIV positive patients were suffering from moderate to severe depression.
P3.199 IMMUNE RESPONSE TO HEPATITIS B VACCINE IN A GROUP OF HEALTH CARE WORKERS AT THE NATIONAL INSTITUE OF HYGIEN -RABAT, MOROCCO
Introduction Healthcare workers are one of the most at risk population of infection with hepatitis B virus (HBV). Our study aims to evaluate the practices and knowledge on the risk of HBV infection and to determine the immune status against HBV among the staff of the National Institute of Hygien (NIH). Methods This is a descriptive cross-sectional study that involved 47 participants belonging to different categories of the NIH staff. After providing a written consent for participation, recruts answered a questionnaire developed from the WHO guidelines.
The assessment of the immune status focused on the screening and quantification of serological markers: HBs Ag, HBs Ab, Hbc Ab by an automated technology using chemiluminescence on the system Cobas E411 (Roche Diagnostics, USA). Results The average age of participants was 45±8 years. All respondents (n=47) confirmed their knowledge of modes of transmission of parenteral hepatitis. Moreover, 72% (n=34) recognised the liver cirrhosis as a consequence of HVB infection. The association of hepatic carcinoma with HBV infection has been acknowledged by 44% (n=21) Introduction HCV is the most common virus affecting the world's 16 million injection drug users (IDUs). It is estimated that close to 3 million IDUs are living with HIV and some studies indicate that over 90% of IDUs infected with HIV are also infected with HCV. The main objective of the study is to determine the correlates of HIV, HCV, and HIV/HCV coinfection among injecting drug users in three states of India. Methods Data were obtained from a bio-behavioural surveyIntegrated Behavioural and Biological Assessment (2009-10) (n=1977) in the high prevalence of HIV states of India among injecting drug users, Manipur, Maharashtra, and Nagaland. The respondent-driven sampling method was used to collect the eligible respondent. Dependent variables for this study was HIV prevalence, HCV prevalence, and HIV/HCV co-infection. Bivariate and multivariate binary logistics regression were used for the analysis. Results The prevalence of HIV, HCV and HIV/HCV co-infection varies from 15 percent to 45 percent among IDUs. It was reported that there was the significant association between HIV, HCV and HIV/HCV co-infection and socio-demographic and risky injecting behaviour. Further Multivariate analysis shows that these infections were more probable among IDUs,1-5 years of schooling, widowed/separated/divorced, longer duration of drug use and drawing-up drug solution from a common container. Further, Longer duration between first drug use and first injecting drugs use (AOR=2.1, p<0.05) and draw up drug solution from a common container 
